News
An alternative drug to antibiotics receives the boost from the CaixaImpulse Consolidate program
An alternative to the use of antibiotics created by the group of Dr. Rafael Mañez, from the Bellvitge Biomedical Research Institute (IDIBELL) and the Bellvitge University Hospital (HUB), has been selected by the CaixaImpulse Consolidate program. The project will receive funding of up to 300,000 euros and personalized support in the transfer process to the […]
IDIBELL announces that it will baptize its spaces with the name of world-renowned women scientist
March 8 marks the International Women’s Day. With the aim of giving visibility and vindicating the decisive role that the women scientists have had throughout history, IDIBELL has announced an action in coming weeks. In recent years there have been important organizational changes in the IDIBELL research environment, such as the creation of Research Programs, […]
The papillomavirus vaccine prevents 90% of cervical cancers
An international multicenter study provides, for the first time, global estimations of the impact of human papillomavirus (HPV), and its vaccine, on the main types of associated cancer.
The research, the most rigorous and the widest to the date, has collected more than 18,000 samples from 50 countries.
The results reveal the high impact of the HPV vaccine on cancer prevention, being able to prevent 90% of cervical cancer.
IDIBELL holds the Kickoff Meeting AES 2019 Health Research Projects funded by the ISCIII
Last 27th of February, IDIBELL Kickoff Meeting AES 2019 took place at Mariano Rovira’s room from Duran and Reynals Hospital. This event was aimed at all researchers that have been awarded the Health Research Project in the “2019 Convene of the Strategic Action in Health 2017-2020” of Health Institute Carlos III. During the session, inaugurated […]
Bellvitge Hospital and IDIBELL validates a new test to predict opportunistic virus infection risk in kidney transplant patients
A clinical trial in five hospitals showed the clinical efficacy of this new diagnostic tool. The new test represents a step forward in personalized medicine in the field of transplants.
New results on the function of the tumor suppressor HERC protein
The RAF protein could be a therapeutical target to treat the tumor growth in regulated pathways by the p38 protein, according to a new study published in the journal Scientific Reports by a team of experts of the Faculty of Medicine and Health Sciences of the UB and the Bellvitge Institute for Biomedical Research (IDIBELL). The study […]
A new model of the worm C. elegans to progress in the study of a rare disease of the nervous system
The IDIBELL Neurometabolic Diseases group, with international collaboration, has identified a model of chromosome X-linked adrenoleukodystrophy (x-ALD) in the earthworm C. elegans, this is a rare disorder of the nervous system with no treatment available.
The model will permit to accelerate and reduce the price of the research, which is studying the mechanisms and the possible pharmacological targets for the neuronal alterations of this disease.
The earliest results of studies with this organism point to glial cells as a man responsible for the neurological damage caused by the disease.
The European Commission grants IDIBELL two individual Marie Sklodowska-Curie fellowships
On February 3, the results of the 2019 call for the European program ‘Marie Sklodowska-Curie Actions – Individual Fellowships’ (MSCA IF) were published. The objective of this initiative is to promote the mobility and innovation of the intellectual capital of Europe. It has therefore a budget (this edition, €296.49 million) aimed at subsidizing the training […]
MRI could predict the effectiveness of a surgical intervention to treat one type of epilepsy
There are epilepsy patients due to sclerosis of the hippocampus who, after their removal, continue to suffer episodes of crisis. In this study, they define a method of measuring hippocampal connectivity, in the hemisphere not damaged by epilepsy, which could help predict the efficiency of surgery before the intervention, and thus better define the risks and advantages that it may entail.